Pangea Natural Food, Inc. (PNGA) AI Stock Analysis

• Market Cap: C$11.26M
• Dividend Yield: N/A
• Average Volume (3M): 153.06K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.93
• Revenue Growth: -49.04%
• EPS Growth: 15.66%
• Country: CA
• Employees: 2
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): N/A
• Shares Outstanding: 28,517,008
• 10 Day Avg. Volume: 179,826
• 30 Day Avg. Volume: 153,063
• PEG Ratio: -0.05
• Price to Book (P/B): 10.48
• Price to Sales (P/S): 196.00
• P/FCF Ratio: -4.18
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 48 Neutral
• Price Target: C$0.47 ▲(45.31% Upside)
• Action: Reiterated Date: 03/07/26
• Date: Action: Reiterated 03/07/26

The score is held down primarily by weak financial performance—persistent losses and accelerating cash burn—despite low leverage. Technicals are supportive with strong momentum above major moving averages, but overbought indicators temper the upside. Valuation remains constrained by negative earnings and no dividend support.

Positive Factors

Low Leverage

Minimal debt gives Pangea durable financial flexibility: low fixed interest costs and reduced insolvency risk. Over the next 2–6 months this limits immediate refinancing pressure, allowing management to prioritize operational recovery or strategic funding without heavy interest burdens.

Top-line Acceleration

A large reported revenue rebound signals accelerating demand and potential product traction. If sustained, growing revenue over the medium term can provide scale to absorb fixed costs, improve gross margin leverage and support a path to positive cash conversion within several quarters.

Equity Turnaround

Equity moving from negative to positive in 2025 indicates structural balance-sheet repair, improving solvency metrics and creditor confidence. This creates stronger capacity for capital raises or strategic investment decisions over the coming months without immediate solvency constraints.

Negative Factors

Negative Cash Flow

Persistent operating and free cash outflows, with cash burn accelerating in 2025, create ongoing funding needs. Over a 2–6 month horizon this raises dilution and refinancing risk, constrains investment in growth initiatives, and limits the company’s ability to self-fund operations.

Widening Losses

The company has not converted revenue into sustainable earnings; losses widened materially in 2025. Structurally weak margins and recurring net losses threaten longer-term viability unless cost structure or pricing is improved, pressuring profitability over coming quarters.

Revenue Volatility

Large swings in revenue reduce predictability of cash flows and make planning difficult. This instability increases the chance that recent growth is not durable, complicates supply chain and hiring choices, and raises the likelihood of recurring financing needs over the medium term.

Pangea Natural Food, Inc. Business Overview & Revenue Model

Company Description

Pangea Natural Foods Inc. produces and sells plant-based patties in Canada and the United States. The company offers Old Fashioned Ghee, a butter product; and plant-based Chickn' bites, a vegan nugget. It distributes its products through e-commerce platforms, retail outlets, and wholesale networks. The company was formerly known as Plant-Faced Foods Ltd. and changed its name to Pangea Natural Foods Inc. in September 2021. Pangea Natural Foods Inc. was incorporated in 2021 and is headquartered in Surrey, Canada.

How the Company Makes Money

null

Pangea Natural Food, Inc. Financial Statement Overview

Summary

Financials indicate weak fundamentals: volatile revenue, consistently negative profitability with widening losses in 2025, and persistent (worsening) operating and free cash flow outflows. The balance sheet benefits from minimal debt and improved equity in 2025, but ongoing cash burn and negative margins remain the dominant risk.

Income Statement

Annual results show highly volatile revenue (sharp contraction through 2024 followed by a small-dollar rebound in 2025) and persistent losses. Profitability is weak: gross profit swings from positive to deeply negative, and operating earnings and net income are consistently negative, with losses widening materially in 2025 despite revenue growth off a very low base. The main strength is the recent top-line acceleration, but the current cost structure and negative margins indicate the business has not converted growth into sustainable earnings.

Balance Sheet

Leverage is low (total debt is minimal to zero across periods), which reduces financial risk. However, equity quality has been unstable—stockholders’ equity was negative in 2023–2024 before turning positive in 2025—signaling prior balance-sheet stress and accumulated losses. Assets increased sharply in 2025, but given ongoing losses, the key weakness is whether the balance sheet can remain resilient without consistent profitability.

Cash Flow

Cash generation is consistently negative, with operating cash flow and free cash flow both outflows every year shown. Cash burn accelerated significantly in 2025, indicating higher funding needs and weaker near-term self-sufficiency. A positive is that debt is not being used heavily, but the recurring negative free cash flow profile raises dilution/financing risk unless operating performance improves.

Breakdown	Oct 2025	Jan 2025	Jan 2024	Jan 2023	Oct 2021
Income Statement
Total Revenue	49.72K	12.20K	285.59K	580.99K	68.50K
Gross Profit	-69.17K	6.91K	-32.79K	40.97K	-67.25K
EBITDA	-2.16M	-917.21K	-1.64M	-855.30K	-172.28K
Net Income	-4.53M	-1.03M	-1.66M	-1.13M	-173.19K
Balance Sheet
Total Assets	1.33M	182.29K	191.72K	620.34K	1.34M
Cash, Cash Equivalents and Short-Term Investments	960.01K	140.09K	51.64K	75.95K	807.57K
Total Debt	0.00	17.83K	0.00	0.00	0.00
Total Liabilities	401.26K	732.74K	330.00K	408.57K	116.82K
Stockholders Equity	929.72K	-550.45K	-138.28K	211.76K	1.23M
Cash Flow
Free Cash Flow	-2.33M	-439.41K	-980.68K	-725.80K	-590.75K
Operating Cash Flow	-2.33M	-439.41K	-980.68K	-718.60K	-529.76K
Investing Cash Flow	-270.17K	0.00	0.00	-7.20K	-60.98K
Financing Cash Flow	3.40M	527.86K	956.37K	-1.32K	1.40M

Pangea Natural Food, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.32
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:PNGA, the sentiment is Positive. The current price of 0.32 is below the 20-day moving average (MA) of 0.36, above the 50-day MA of 0.28, and below the 200-day MA of 0.32, indicating a bullish trend. The MACD of 0.05 indicates Negative momentum. The RSI at 58.36 is Neutral, neither overbought nor oversold. The STOCH value of 70.18 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:PNGA.

Pangea Natural Food, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
PNGA	48 Neutral	C$11.26M	-2.15	-241.90%	―	-49.04%	15.66%
NPRA	48 Neutral	C$13.09M	33.38	―	―	69.12%	43.02%
BABY	44 Neutral	C$2.43M	-3.11	5435.74%	―	-25.08%	65.57%
MEAT	41 Neutral	C$1.03M	-4.08	―	―	-3.76%	86.34%
ISTK	25 Underperform	C$85.71M	-5.47	81.87%	―	30.02%	35.29%

Pangea Natural Food, Inc. Corporate Events

Pangea Wellness to Rebrand as The Precision Peptide Company on March 18

Pangea Wellness Inc. is rebranding as The Precision Peptide Company Inc., reflecting its focus on clean-label foods and advanced wellness solutions, including needle-free peptide therapies offered through its Amino Innovations subsidiary. The North American firm specializes in products that support recovery, cognitive performance, and general health.

The company confirmed that its name change will take effect on March 18, 2026, when its common shares will begin trading on the CSE under the new symbol BPC, with updated CUSIP and ISIN identifiers but unchanged share capital. The move signals a strategic emphasis on precision peptide technologies while maintaining continuity for shareholders, as the capital structure remains intact despite the branding and ticker transition.

The most recent analyst rating on (TSE:PNGA) stock is a Hold with a C$0.35 price target. To see the full list of analyst forecasts on Pangea Natural Food, Inc. stock, see the TSE:PNGA Stock Forecast page.

Pangea Wellness Plans Rebrand as The Precision Peptide Company

Pangea Wellness Inc., a North American manufacturer of clean-label foods and innovative wellness products, operates through its Amino Innovations subsidiary to provide needle-free peptide therapies that target recovery, cognitive performance, and general health. This focus aligns the company with growing consumer demand for non-invasive, science-based wellness interventions.

The company plans to change its name to The Precision Peptide Company Inc., subject to Canadian Securities Exchange approval, and will adopt the new stock symbol BPC in place of PNGA. The rebranding underscores a strategic emphasis on its peptide-based therapeutic platform, signaling a tighter alignment of corporate identity with its core technology and potentially sharpening its profile among investors and partners in the wellness and biotech-adjacent markets.

The most recent analyst rating on (TSE:PNGA) stock is a Hold with a C$0.37 price target. To see the full list of analyst forecasts on Pangea Natural Food, Inc. stock, see the TSE:PNGA Stock Forecast page.